District 211 Upholds Agreement Over Trans Student
Total Page:16
File Type:pdf, Size:1020Kb
VOL 31, NO. 11 DEC. 9, 2015 www.WindyCityMediaGroup.com Attorney Owen Daniel-McCarter speaks at the Township High School District 211 Board of Education meeting. Photo by Gretchen Rachel Hammond SHOWDOWN District 211 upholds agreement over trans student BY MATT SIMONETTE The student, who has maintained her anonymity through- out, will be allowed to access a designated part of the locker A Northwest suburban school district voted Dec. 7 to uphold room, separated by a curtain, to change. Additionally, the an agreement that will allow a Palatine trans student to uti- agreement applies only to the student in question, and will lize her school’s girls’ locker room facilities. not be a set policy applicable to other students. More than 600 people attended the emergency meeting of The board presented a Dec. 7 letter from OCR Assistant Sec- the Township High School District 211 Board of Education, retary for Civil Rights Catherine L. Lhamon to District 211’s which was called at James B. Conant High School in Hoff- attorneys clarifying those terms: “… [The] agreement provi- man Estates, in the heated aftermath of an initial agreement sions specific to locker room access apply only to Student A reached with the Office of Civil Rights (OCR) of the Depart- and the District’s agreement to provide Student A access to ment of Education in the early morning of Dec. 3. locker rooms is based on the student’s representation that ‘GIRL’ TALK Shortly after that agreement was announced, the board she will change in the private changing stations.” Under the Actor Eddie Redmayne discusses playing a ended up in disputes with both the OCR and American Civil agreement, the district admits to no violations of federal law. transgender woman in The Danish Girl. Liberties Union–Illinois, which represented the student, over Lhamon had made statements to the media the week before Photo courtesy of Focus Features 23 the resolution’s terms, and called the Dec. 7 meeting to clar- suggesting that the student would have unrestricted access ify the matter. Turn to page 10 POLICE STATEMENTS WORLD AIDS DAY SARAH PAULSON Chicago LGBT politicians weigh in on Events marking the occasion ranged from panels to the Actress talks about coming out, police chief’s resignation. annual World of Chocolate. new movie Carol. Photo of Ald. Ray Lopez 8 Photo from World of Chocolate by Kat Fitzgerald 14-16 Photo courtesy of Weinstein 26 SEE IT IN CHICAGO FIRST! TH TH A WORLD PREMIERE DEC. 13 – JAN. 17 FROM THE DIRECTOR OF KINKY BOOTS 800-775-2000 AND Groups 10+: 312-977-1710 ON YOUR FEET! ANDRÉ GEORGIA STEFANIE LILLIAS TO LEARN MORE, VISIT: DE SHIELDS ENGEL POWERS WHITE MATTHEW MURPHY BY PHOTOS GOTTADANCEONBROADWAY.COM 2 Dec. 9, 2015 WINDY CITY TIMES Actual Size One pill contains elvitegravir, cobicistat, emtricitabine, New Genvoya® and tenofovir alafenamide (TAF). is now available Ask your healthcare provider if GENVOYA is right for you. To learn more visit GENVOYA.com Please see Brief Summary of Patient Information with important warnings on the following pages. GENC0003_WindyCity_10.x13.5_Sprd.indd 1-2 12/3/15 3:23 PM WINDY CITY TIMES Dec. 9, 2015 3 Actual Size One pill contains elvitegravir, cobicistat, emtricitabine, New Genvoya® and tenofovir alafenamide (TAF). is now available Ask your healthcare provider if GENVOYA is right for you. To learn more visit GENVOYA.com Please see Brief Summary of Patient Information with important warnings on the following pages. GENC0003_WindyCity_10.x13.5_Sprd.indd 1-2 12/3/15 3:23 PM 4 Dec. 9, 2015 WINDY CITY TIMES Brief Summary of Patient Information What is GENVOYA? What should I tell my healthcare provider What are the possible side effects of GENVOYA? about GENVOYA GENVOYA is a prescription medicine that is used without other HIV-1 before taking GENVOYA? GENVOYA may cause serious side effects, including: GENVOYA (jen-VOY-uh) medicines to treat HIV-1 in people 12 years of age and older: Before taking GENVOYA, tell your healthcare provider if you: • See “What is the most important information I should know (elvitegravir, cobicistat, emtricitabine, and tenofovir • who have not received HIV-1 medicines in the past or • have liver problems including hepatitis B infection about GENVOYA?” alafenamide) tablets • to replace their current HIV-1 medicines in people who have • have kidney or bone problems • Changes in body fat can happen in people who take HIV-1 been on the same HIV-1 medicines for at least 6 months, have medicine. These changes may include increased amount of fat Important: Ask your healthcare provider or pharmacist about • have any other medical conditions medicines that should not be taken with GENVOYA. an amount of HIV-1 in their blood (“viral load”) that is less than in the upper back and neck (“buffalo hump”), breast, and around • are pregnant or plan to become pregnant. It is not known if There may be new information about GENVOYA. This information is only 50 copies/mL, and have never failed past HIV-1 treatment GENVOYA can harm your unborn baby. Tell your healthcare the middle of your body (trunk). Loss of fat from the legs, arms a summary and does not take the place of talking with your healthcare HIV-1 is the virus that causes AIDS. provider if you become pregnant while taking GENVOYA. and face may also happen. The exact cause and long-term health ® effects of these conditions are not known. provider about your medical condition or treatment. GENVOYA contains the prescription medicines elvitegravir (VITEKTA ), Pregnancy registry: there is a pregnancy registry for women cobicistat (TYBOST®), emtricitabine (EMTRIVA®) and tenofovir alafenamide. • Changes in your immune system (Immune Reconstitution What is the most important information who take HIV-1 medicines during pregnancy. The purpose of this It is not known if GENVOYA is safe and effective in children under Syndrome) can happen when you start taking HIV-1 medicines. I should know about GENVOYA? registry is to collect information about the health of you and your 12 years of age. baby. Talk with your healthcare provider about how you can take Your immune system may get stronger and begin to fi ght infections that have been hidden in your body for a long time. Tell GENVOYA can cause serious side effects, including: When used to treat HIV-1 infection, GENVOYA may: part in this registry. your healthcare provider right away if you start having any new • Build-up of lactic acid in your blood (lactic acidosis). • Reduce the amount of HIV-1 in your blood. • are breastfeeding or plan to breastfeed. Do not breastfeed if you symptoms after starting your HIV-1 medicine. Lactic acidosis may happen in some people who take GENVOYA. This is called “viral load”. take GENVOYA. Lactic acidosis is a serious medical emergency that can lead • New or worse kidney problems, including kidney failure. Your • Increase the number of CD4+ (T) cells in your blood that help – You should not breastfeed if you have HIV-1 because of the risk to death. Lactic acidosis can be hard to identify early, because healthcare provider should do blood and urine tests to check your fi ght off other infections. of passing HIV-1 to your baby. kidneys before you start and while you are taking GENVOYA. Your the symptoms could seem like symptoms of other health problems. Reducing the amount of HIV-1 and increasing the CD4+ (T) cells in your – At least one of the medicines in GENVOYA can pass to your Call your healthcare provider right away if you get any of the healthcare provider may tell you to stop taking GENVOYA if you blood may help improve your immune system. This may reduce your baby in your breast milk. It is not known if the other medicines develop new or worse kidney problems. following symptoms, which could be signs of lactic acidosis: risk of death or getting infections that can happen when your immune in GENVOYA can pass into your breast milk. • Bone problems can happen in some people who take GENVOYA. • feel very weak or tired system is weak (opportunistic infections). – Talk with your healthcare provider about the best way to feed Bone problems may include bone pain, softening or thinning • have unusual (not normal) muscle pain GENVOYA does not cure HIV-1 infection or AIDS. You must stay on your baby. (which may lead to fractures). Your healthcare provider may need continuous HIV-1 therapy to control HIV-1 infection and decrease • have trouble breathing Tell your healthcare provider about all the medicines you take, to do tests to check your bones. HIV-related illnesses. including prescription and over-the-counter medicines, vitamins, and • have stomach pain with nausea or vomiting The most common side effect of GENVOYA is nausea. Avoid doing things that can spread HIV-1 infection to others: herbal supplements. Other medicines may affect how GENVOYA works. • feel cold, especially in your arms and legs Tell your healthcare provider if you have any side effect that Do not share or re-use needles or other injection equipment. Some medicines may interact with GENVOYA. Keep a list of your • feel dizzy or lightheaded • bothers you or that does not go away. Do not share personal items that can have blood or body fl uids medicines and show it to your healthcare provider and pharmacist • have a fast or irregular heartbeat • • These are not all the possible side effects of GENVOYA. For more on them, like toothbrushes and razor blades. when you get a new medicine. information, ask your healthcare provider or pharmacist. • Severe liver problems. Severe liver problems may happen in You can ask your healthcare provider or pharmacist for a list of • Do not have any kind of sex without protection.